/
Leuk Lymphoma
Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals
- S. Denker
- A. Bittner
- M. Frick
- J. Kase
- J. Hoffmann
- C. Trenker
- U. Keller
- C. Bogner
- A. Hüttmann
- J. Dürig
- M. Janz
- S. Mathas
- R. Marks
- U. Krohn
- I.K. Na
- L. Bullinger
- C.A. Schmitt